Connor, Clark & Lunn Investment Management (CC&L)’s Applied Genetic Technologies Corporation AGTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-28,909
| Closed | -$118K | – | 1132 |
|
|
2020
Q4 | $118K | Sell |
28,909
-11,831
| -29% | -$48.3K | ﹤0.01% | 853 |
|
|
2020
Q3 | $198K | Sell |
40,740
-21,721
| -35% | -$106K | ﹤0.01% | 837 |
|
|
2020
Q2 | $346K | Buy |
62,461
+2,483
| +4% | +$13.8K | ﹤0.01% | 822 |
|
|
2020
Q1 | $197K | Buy |
+59,978
| New | +$197K | ﹤0.01% | 870 |
|
|
2019
Q1 | – | Sell |
-52,925
| Closed | -$132K | – | 1074 |
|
|
2018
Q4 | $132K | Sell |
52,925
-8,050
| -13% | -$20.1K | ﹤0.01% | 889 |
|
|
2018
Q3 | $445K | Sell |
60,975
-3,200
| -5% | -$23.4K | ﹤0.01% | 721 |
|
|
2018
Q2 | $237K | Buy |
64,175
+3,500
| +6% | +$12.9K | ﹤0.01% | 929 |
|
|
2018
Q1 | $234K | Hold |
60,675
| – | – | ﹤0.01% | 643 |
|
|
2017
Q4 | $218K | Sell |
60,675
-9,500
| -14% | -$34.1K | ﹤0.01% | 713 |
|
|
2017
Q3 | $277K | Sell |
70,175
-700
| -1% | -$2.76K | ﹤0.01% | 713 |
|
|
2017
Q2 | $361K | Buy |
70,875
+7,400
| +12% | +$37.7K | ﹤0.01% | 655 |
|
|
2017
Q1 | $438K | Buy |
63,475
+23,400
| +58% | +$161K | ﹤0.01% | 649 |
|
|
2016
Q4 | $375K | Buy |
40,075
+20,975
| +110% | +$196K | ﹤0.01% | 670 |
|
|
2016
Q3 | $187K | Buy |
+19,100
| New | +$187K | ﹤0.01% | 740 |
|
|
2016
Q1 | – | Sell |
-12,950
| Closed | -$264K | – | 924 |
|
|
2015
Q4 | $264K | Sell |
12,950
-100
| -0.8% | -$2.04K | ﹤0.01% | 653 |
|
|
2015
Q3 | $171K | Buy |
+13,050
| New | +$171K | ﹤0.01% | 653 |
|